SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001140361-23-003612 from SANUWAVE Health, Inc. (SNWV) (CIK 0001417663) (SNWV)

SANUWAVE Health, Inc. (SNWV) (CIK 0001417663)
Date: Jan. 31, 2023 · CIK: 0001417663 · Accession: 0001140361-23-003612

AI Filing Summary & Sentiment

File numbers found in text: 333-267731

Referenced dates: October 17, 2022

Date
January 31, 2023
Author
Not clearly detected
Form
CORRESP
Company
SANUWAVE Health, Inc. (SNWV) (CIK 0001417663)

Letter

Division of Corporation Finance Office of Industrial Applications and Services Re: SANUWAVE Health, Inc. Registration Statement on Form S-1 Filed October 4, 2022 File No. 333-267731

Dear Mr. Richie and Ms. Park:

On behalf of SANUWAVE Health, Inc. (the “Company”), we are transmitting the following response of the Company to the comment of the Securities and Exchange Commission’s staff (the “Staff”) as set forth in the letter of Benjamin Riche and Jane Park, dated October 17, 2022, to the Registration Statement on Form S-1 filed with the Securities and Exchange Commission on October 4, 2022.

The Company is concurrently filing via EDGAR Amendment No. 2 to the Registration Statement on Form S-1 (the “Registration Statement”). The responses herein were provided to this firm by the Company. In this letter, we have recited the comment from the Staff in italicized, bold type and have followed the comment with the Company’s response in regular type.

Registration Statement on Form S-1

Cover Page

1.

We note that your common stock is quoted on the OTC Pink market and you state that selling stockholders may sell their shares at prevailing market prices. Please note that the OTC Pink market is not an established public trading market into which a selling stockholder may offer and sell shares at other than a fixed price. Accordingly, please revise your disclosure throughout to disclose a fixed price at which the selling stockholders will offer and sell shares until your shares are listed on a national securities exchange or quoted on the OTC Bulletin Board, OTCQX, or OTCQB, at which time they may be sold at prevailing market prices. Refer to Item 501(b)(3) of Regulation S-K.

Company Response: In response to the Staff’s comment, the Registration Statement has been revised to reflect the fact that the Company’s common stock is now quoted on the OTCQB.

Respectfully,
FAEGRE DRINKER BIDDLE & REATH LLP

Show Raw Text
CORRESP
1
filename1.htm

          faegredrinker.com

            Faegre Drinker Biddle & Reath LLP

            2200 Wells Fargo Center

            90 S. Seventh Street

            Minneapolis, Minnesota 55402

            +1 612 766 7000 main

            +1 612 766 1600 fax

    By EDGAR

    January 31, 2023

    Benjamin Richie

    Jane Park

    U.S. Securities and Exchange Commission

    Division of Corporation Finance

    Office of Industrial Applications and Services

    100 F Street, NE

    Washington, DC 20549

          Re:

            SANUWAVE Health, Inc.

              Registration Statement on Form S-1 Filed October 4, 2022

              File No. 333-267731

    Dear Mr. Richie and Ms. Park:

    On behalf of SANUWAVE Health, Inc. (the “Company”), we are transmitting the following response of the Company to the comment of the Securities and Exchange Commission’s staff (the
      “Staff”) as set forth in the letter of Benjamin Riche and Jane Park, dated October 17, 2022, to the Registration Statement on Form S-1 filed with the Securities and Exchange Commission on October 4, 2022.

    The Company is concurrently filing via EDGAR Amendment No. 2 to the Registration Statement on Form S-1 (the “Registration Statement”).  The responses herein were provided to this
      firm by the Company. In this letter, we have recited the comment from the Staff in italicized, bold type and have followed the comment with the Company’s response in regular type.

    Registration Statement on Form S-1

    Cover Page

          1.

            We note that your common stock is quoted on the OTC Pink market and you state that selling stockholders may sell their shares at prevailing market prices. Please note that the OTC Pink market
              is not an established public trading market into which a selling stockholder may offer and sell shares at other than a fixed price. Accordingly, please revise your disclosure throughout to disclose a fixed price at which the selling
              stockholders will offer and sell shares until your shares are listed on a national securities exchange or quoted on the OTC Bulletin Board, OTCQX, or OTCQB, at which time they may be sold at prevailing market prices. Refer to Item 501(b)(3)
              of Regulation S-K.

    Company Response: In response to the Staff’s comment, the Registration Statement has been revised to reflect the fact that the Company’s common stock is now
      quoted on the OTCQB.

    Respectfully,

    FAEGRE DRINKER BIDDLE & REATH LLP

            /s/ Ben A. Stacke

            Ben A. Stacke

    Enclosures

          cc:

            Kevin A. Richardson, II, SANUWAVE Health, Inc.

              Toni Rinow, SANUWAVE Health, Inc.